Valuation: Guard Therapeutics International AB

Market Cap 32.27M 3.34M 2.92M 2.7M 2.48M 4.69M 322M 4.77M 12.64M 157M 12.53M 12.26M 546M P/E 2024
-2.24x
P/E 2025 -0.24x
Enterprise Value -17.56M -1.82M -1.59M -1.47M -1.35M -2.55M -175M -2.59M -6.88M -85.62M -6.82M -6.67M -297M EV / Sales 2024
-
EV / Sales 2025 -
Free-Float
65.85%
Yield 2024 *
-
Yield 2025 -

Last Transcript: Guard Therapeutics International AB

1 day-3.03%
1 week+2.56%
1 month+3.09%
3 months+27.80%
6 months-19.60%
Current year+8.84%
1 week 1.45
Extreme 1.45
1.8
1 month 1.4
Extreme 1.402
1.8
Current year 0.88
Extreme 0.881
2.35
1 year 0.88
Extreme 0.881
27
3 years 0.88
Extreme 0.881
49.8
5 years 0.88
Extreme 0.881
112.5
10 years 0.88
Extreme 0.881
3,050
Manager TitleAgeSince
Chief Executive Officer 50 15/01/2019
Director of Finance/CFO 53 14/09/2020
Chief Tech/Sci/R&D Officer 66 01/01/2022
Director TitleAgeSince
Director/Board Member 63 29/05/2019
Director/Board Member 56 29/05/2019
Chairman 70 01/05/2021
Date Insider Type Main position Quantity % Market Cap.
2/28/23 A Free 1,344,000 0.2672%
2/28/23 A Free

Chief Executive Officer

9,450,000 1.8784%
2/28/23 A Free 756,000 0.1503%
Change 5-day change 1-year change 3-year change Capi.($)
-3.03%+2.56%-92.08%-76.12% 3.45M
-0.49%-3.58%-0.84%+2.13% 49.18B
-3.10%-3.47%+370.99%+567.62% 39.58B
-0.46%+3.98%+5.44%+60.79% 34.69B
-1.14%-1.90%+26.94%-9.56% 34.42B
-1.82%-1.48%+0.52%+32.02% 27.11B
-3.54%-6.91% - - 16.21B
-1.82%-1.91%+69.28%+112.51% 15.36B
+1.17%+3.10%+15.87%+16.79% 14.05B
-2.25%-0.92%+15.77%-32.78% 13.02B
Average -1.65%+0.42%+45.77%+74.82% 24.36B
Weighted average by Cap. -1.43%-0.38%+75.91%+117.64%

Financials

2024 2025
Net sales - -
Net income -96.07M -9.93M -8.7M -8.05M -7.39M -13.97M -958M -14.19M -37.64M -468M -37.3M -36.49M -1.63B -109M -11.26M -9.86M -9.12M -8.38M -15.83M -1.09B -16.08M -42.65M -531M -42.27M -41.34M -1.84B
Net Debt -54.19M -5.6M -4.91M -4.54M -4.17M -7.88M -540M -8M -21.23M -264M -21.04M -20.58M -917M -49.83M -5.15M -4.51M -4.17M -3.83M -7.25M -497M -7.36M -19.52M -243M -19.35M -18.92M -844M
Logo Guard Therapeutics International AB
Guard Therapeutics International AB (publ), formerly A1M Pharma AB, is a Sweden-based company, which is active within the healthcare sector. The Company conducts development and commercialization of treatment and diagnostics based on the alpha-1-microglobulin (A1M) protein. The protein serves as a radical inhibitor, an antioxidant, a protector against free hemoglobin and a tissue repairer. A1M is a candidate for different therapeutic and diagnostic uses, such as alleviation of autoimmune diseases and stroke treatment. The Company works with the protein and conducts research at the Biomedical Center in Lund University, Sweden. The Company develops a drug for intravenous treatment of preeclampsia, a condition that can occur during pregnancy and can contribute to premature deliveries.
Employees
12
Date Price Change Volume
20/07/26 SEK 1.600 -3.03% 8,210
17/07/26 SEK 1.650 +3.12% 4,656
16/07/26 SEK 1.600 +3.23% 22,730
15/07/26 SEK 1.550 +0.13% 10,292
14/07/26 SEK 1.548 -1.90% 2,933

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. GUARD Stock